Fundamentally Different Mechanisms
TRT replaces testosterone directly — you administer exogenous testosterone, bypassing the body’s natural production. Peptide therapy for GH optimization (Sermorelin, CJC-1295 + Ipamorelin) stimulates your own pituitary to produce growth hormone — working with the body’s feedback systems rather than replacing them.
The Suppression Question
TRT suppresses the body’s natural testosterone production through negative feedback on the hypothalamic-pituitary-gonadal axis. Cessation of TRT without proper protocol can leave patients with suppressed natural production. GH secretagogue peptides do not suppress natural GH production — they stimulate it. The pituitary retains its feedback regulation.
Who Is a Better Candidate for Each
TRT is typically indicated for patients with documented testosterone deficiency (hypogonadism) confirmed by lab testing. GH peptides are typically considered for patients with age-related GH decline interested in body composition, recovery, and energy without direct hormone replacement. Some patients use both under physician supervision — they address different systems.
Regulatory Status
TRT is FDA-approved for hypogonadism. GH peptides like Sermorelin and CJC-1295 are prescribed off-label through compounding pharmacies. Both require physician prescription and monitoring.